Metagenomi Inc Sustainability Reports
Metagenomi, Inc. is a gene-editing biotechnology company that develops next-generation genetic medicines. The company leverages machine learning and a metagenomics-derived genome editing toolbox to discover and build programmable cellular therapies for patients.
Sector: Professional & technical services
Country: United States
Exchange: Nasdaq
FIGI: BBG00Y5ZXS95
No reports are currently available in our catalogue.